First Trust Capital Management’s Verona Pharma VRNA Stock Holding History

First Trust Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-909,123	Closed	-$97M	–	181
2025 Q3	$97M	Buy	+909,123	New	+$94.9M	6.26%	2

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

First Trust Capital Management's VRNA Position: Q4 2025 in Review

First Trust Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 909,123 shares — an estimated $97M sold.

First Trust Capital Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $97M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

First Trust Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
First Trust Capital Management sold 909,123 Verona Pharma shares in Q4 2025, an estimated $97M.
First Trust Capital Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
First Trust Capital Management's Verona Pharma position peaked at $97M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on First Trust Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.